Kujoo launched non-prescription anti-obesity drug.

Published: 2001-10-23 06:56:00

Updated: 2001-10-23 06:56:00

Amid soaring social interests in the anti-obesity drug Kujoo pharmaceutical company announced on Oct. 18 that they would launch a non-prescription anti-obesity drug named "Exolise" next month,

Unlike Xenical and Reductil, all prescription anti-obesity drugs, Exolise was registered as a non-prescription drug with production plans by importing bulk drugs from Alco Pharma in France. Now, Kujo...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.